Author:
Joo Yun,Kim Hagyeong,Baik Jong Youn
Publisher
Springer Science and Business Media LLC
Subject
Biomedical Engineering,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference84 articles.
1. Walsh, G. and E. Walsh (2022) Biopharmaceutical benchmarks 2022. Nat. Biotechnol. 40: 1722–1760.
2. Wu, S., A. J. Rish, A. Skomo, Y. Zhao, J. K. Drennen, and C. A. Anderson (2021) Rapid serum-free/suspension adaptation: medium development using a definitive screening design for Chinese hamster ovary cells. Biotechnol. Prog. 37: e3154.
3. Huang, Y.-M., W. Hu, E. Rustandi, K. Chang, H. Yusuf-Makagiansar, and T. Ryll (2010) Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol. Prog. 26: 1400–1410.
4. Tihanyi, B. and L. Nyitray (2020) Recent advances in CHO cell line development for recombinant protein production. Drug Discov. Today Technol. 38: 25–34.
5. Zhang, Q., B. Jiang, L. Nelson, S. Huhn, Z. Du, and L. A. Chasin (2022) A multiauxotrophic CHO cell line for the rapid isolation of producers of diverse or high levels of recombinant proteins. Biotechnol. Bioeng. 119: 1392–1404.